Diabetes raises death risk in STEMI patients undergoing angioplasty

01/29/2013 | PhysiciansBriefing.com

A study of 6,298 patients undergoing primary angioplasty for ST-segment elevation myocardial infarction found those with diabetes had higher rates of reinfarction, stent thrombosis, target vessel revascularization and death than those who did not have diabetes. The results were published in Diabetes Care.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY